Cargando…

Identification of a dysregulated CircRNA-associated gene signature for predicting prognosis, immune landscape, and drug candidates in bladder cancer

Increasing evidences have demonstrated that circular RNA (circRNAs) plays a an essential regulatory role in initiation, progression and immunotherapy resistance of various cancers. However, circRNAs have rarely been studied in bladder cancer (BCa). The purpose of this research is to explore new circ...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Chong, Li, Zhi, Zhang, Yinglang, Zhang, Zhe, Wu, Zhouliang, Da, La, Yang, Shaobo, Wang, Zejin, Zhang, Yu, Qie, Yunkai, Zhao, Gangjian, Lin, Yuda, Huang, Shiwang, Zhou, Mingli, Hu, Hailong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589509/
https://www.ncbi.nlm.nih.gov/pubmed/36300085
http://dx.doi.org/10.3389/fonc.2022.1018285
_version_ 1784814322307825664
author Shen, Chong
Li, Zhi
Zhang, Yinglang
Zhang, Zhe
Wu, Zhouliang
Da, La
Yang, Shaobo
Wang, Zejin
Zhang, Yu
Qie, Yunkai
Zhao, Gangjian
Lin, Yuda
Huang, Shiwang
Zhou, Mingli
Hu, Hailong
author_facet Shen, Chong
Li, Zhi
Zhang, Yinglang
Zhang, Zhe
Wu, Zhouliang
Da, La
Yang, Shaobo
Wang, Zejin
Zhang, Yu
Qie, Yunkai
Zhao, Gangjian
Lin, Yuda
Huang, Shiwang
Zhou, Mingli
Hu, Hailong
author_sort Shen, Chong
collection PubMed
description Increasing evidences have demonstrated that circular RNA (circRNAs) plays a an essential regulatory role in initiation, progression and immunotherapy resistance of various cancers. However, circRNAs have rarely been studied in bladder cancer (BCa). The purpose of this research is to explore new circRNAs and their potential mechanisms in BCa. A novel ceRNA-regulated network, including 87 differentially expressed circRNAs (DE-circRNAs), 126 DE-miRNAs, and 217 DE-mRNAs was constructed to better understanding the biological processes using Cytoscape 3.7.1 based on our previously high-throughput circRNA sequencing and five GEO datasets. Subsequently, five randomly selected circRNAs (upregulated circ_0001681; downregulated circ_0000643, circ_0001798, circ_0006117 and circ_0067900) in 20 pairs of BCa and paracancerous tissues were confirmed using qRT-PCR. Functional analysis results determined that 772 GO functions and 32 KEGG pathways were enriched in the ceRNA network. Ten genes (PFKFB4, EDNRA, GSN, GAS1, PAPPA, DTL, TGFBI, PRSS8, RGS1 and TCF4) were selected for signature construction among the ceRNA network. The Human Protein Atlas (HPA) expression of these genes were consistent with the above sequencing data. Notably, the model was validated in multiple external datasets (GSE13507, GSE31684, GSE48075, IMvigor210 and GSE32894). The immune-infiltration was evaluated by 7 published algorithms (i.e., TIMER, CIBERSORT, CIBERSORT-ABS, QUANTISEQ, MCPCOUNTER, XCELL and EPIC). Next, Correlations between riskscore or risk groups and clinicopathological data, overall survival, recognized immunoregulatory cells or common chemotherapeutic agents of BCa patients were performed using wilcox rank test, chi-square test, cox regression and spearman’s correlation analysis; and, these results are significant. According to R package “GSVA” and “clusterProfiler”, the most significantly enriched HALLMARK and KEGG pathway was separately the ‘Epithelial Mesenchymal Transition’ and ‘Ecm Receptor Interaction’ in the high- vs. low-risk group. Additionally, the functional experiments in vitro also revealed that the overexpression of has_circ_0067900 significantly impaired the proliferation, migration, and invasion capacities of BCa cells. Collectively, the results of the current study provide a novel landscape of circRNA-associated ceRNA-regulated network in BCa. The ceRNA-associated gene model which was constructed presented a high predictive performance for the prognosis, immunotherapeutic responsiveness, and chemotherapeutic sensitivity of BCa. And, has_circ_0067900 was originally proposed as tumor suppressor for patients with BCa.
format Online
Article
Text
id pubmed-9589509
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95895092022-10-25 Identification of a dysregulated CircRNA-associated gene signature for predicting prognosis, immune landscape, and drug candidates in bladder cancer Shen, Chong Li, Zhi Zhang, Yinglang Zhang, Zhe Wu, Zhouliang Da, La Yang, Shaobo Wang, Zejin Zhang, Yu Qie, Yunkai Zhao, Gangjian Lin, Yuda Huang, Shiwang Zhou, Mingli Hu, Hailong Front Oncol Oncology Increasing evidences have demonstrated that circular RNA (circRNAs) plays a an essential regulatory role in initiation, progression and immunotherapy resistance of various cancers. However, circRNAs have rarely been studied in bladder cancer (BCa). The purpose of this research is to explore new circRNAs and their potential mechanisms in BCa. A novel ceRNA-regulated network, including 87 differentially expressed circRNAs (DE-circRNAs), 126 DE-miRNAs, and 217 DE-mRNAs was constructed to better understanding the biological processes using Cytoscape 3.7.1 based on our previously high-throughput circRNA sequencing and five GEO datasets. Subsequently, five randomly selected circRNAs (upregulated circ_0001681; downregulated circ_0000643, circ_0001798, circ_0006117 and circ_0067900) in 20 pairs of BCa and paracancerous tissues were confirmed using qRT-PCR. Functional analysis results determined that 772 GO functions and 32 KEGG pathways were enriched in the ceRNA network. Ten genes (PFKFB4, EDNRA, GSN, GAS1, PAPPA, DTL, TGFBI, PRSS8, RGS1 and TCF4) were selected for signature construction among the ceRNA network. The Human Protein Atlas (HPA) expression of these genes were consistent with the above sequencing data. Notably, the model was validated in multiple external datasets (GSE13507, GSE31684, GSE48075, IMvigor210 and GSE32894). The immune-infiltration was evaluated by 7 published algorithms (i.e., TIMER, CIBERSORT, CIBERSORT-ABS, QUANTISEQ, MCPCOUNTER, XCELL and EPIC). Next, Correlations between riskscore or risk groups and clinicopathological data, overall survival, recognized immunoregulatory cells or common chemotherapeutic agents of BCa patients were performed using wilcox rank test, chi-square test, cox regression and spearman’s correlation analysis; and, these results are significant. According to R package “GSVA” and “clusterProfiler”, the most significantly enriched HALLMARK and KEGG pathway was separately the ‘Epithelial Mesenchymal Transition’ and ‘Ecm Receptor Interaction’ in the high- vs. low-risk group. Additionally, the functional experiments in vitro also revealed that the overexpression of has_circ_0067900 significantly impaired the proliferation, migration, and invasion capacities of BCa cells. Collectively, the results of the current study provide a novel landscape of circRNA-associated ceRNA-regulated network in BCa. The ceRNA-associated gene model which was constructed presented a high predictive performance for the prognosis, immunotherapeutic responsiveness, and chemotherapeutic sensitivity of BCa. And, has_circ_0067900 was originally proposed as tumor suppressor for patients with BCa. Frontiers Media S.A. 2022-10-10 /pmc/articles/PMC9589509/ /pubmed/36300085 http://dx.doi.org/10.3389/fonc.2022.1018285 Text en Copyright © 2022 Shen, Li, Zhang, Zhang, Wu, Da, Yang, Wang, Zhang, Qie, Zhao, Lin, Huang, Zhou and Hu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Shen, Chong
Li, Zhi
Zhang, Yinglang
Zhang, Zhe
Wu, Zhouliang
Da, La
Yang, Shaobo
Wang, Zejin
Zhang, Yu
Qie, Yunkai
Zhao, Gangjian
Lin, Yuda
Huang, Shiwang
Zhou, Mingli
Hu, Hailong
Identification of a dysregulated CircRNA-associated gene signature for predicting prognosis, immune landscape, and drug candidates in bladder cancer
title Identification of a dysregulated CircRNA-associated gene signature for predicting prognosis, immune landscape, and drug candidates in bladder cancer
title_full Identification of a dysregulated CircRNA-associated gene signature for predicting prognosis, immune landscape, and drug candidates in bladder cancer
title_fullStr Identification of a dysregulated CircRNA-associated gene signature for predicting prognosis, immune landscape, and drug candidates in bladder cancer
title_full_unstemmed Identification of a dysregulated CircRNA-associated gene signature for predicting prognosis, immune landscape, and drug candidates in bladder cancer
title_short Identification of a dysregulated CircRNA-associated gene signature for predicting prognosis, immune landscape, and drug candidates in bladder cancer
title_sort identification of a dysregulated circrna-associated gene signature for predicting prognosis, immune landscape, and drug candidates in bladder cancer
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9589509/
https://www.ncbi.nlm.nih.gov/pubmed/36300085
http://dx.doi.org/10.3389/fonc.2022.1018285
work_keys_str_mv AT shenchong identificationofadysregulatedcircrnaassociatedgenesignatureforpredictingprognosisimmunelandscapeanddrugcandidatesinbladdercancer
AT lizhi identificationofadysregulatedcircrnaassociatedgenesignatureforpredictingprognosisimmunelandscapeanddrugcandidatesinbladdercancer
AT zhangyinglang identificationofadysregulatedcircrnaassociatedgenesignatureforpredictingprognosisimmunelandscapeanddrugcandidatesinbladdercancer
AT zhangzhe identificationofadysregulatedcircrnaassociatedgenesignatureforpredictingprognosisimmunelandscapeanddrugcandidatesinbladdercancer
AT wuzhouliang identificationofadysregulatedcircrnaassociatedgenesignatureforpredictingprognosisimmunelandscapeanddrugcandidatesinbladdercancer
AT dala identificationofadysregulatedcircrnaassociatedgenesignatureforpredictingprognosisimmunelandscapeanddrugcandidatesinbladdercancer
AT yangshaobo identificationofadysregulatedcircrnaassociatedgenesignatureforpredictingprognosisimmunelandscapeanddrugcandidatesinbladdercancer
AT wangzejin identificationofadysregulatedcircrnaassociatedgenesignatureforpredictingprognosisimmunelandscapeanddrugcandidatesinbladdercancer
AT zhangyu identificationofadysregulatedcircrnaassociatedgenesignatureforpredictingprognosisimmunelandscapeanddrugcandidatesinbladdercancer
AT qieyunkai identificationofadysregulatedcircrnaassociatedgenesignatureforpredictingprognosisimmunelandscapeanddrugcandidatesinbladdercancer
AT zhaogangjian identificationofadysregulatedcircrnaassociatedgenesignatureforpredictingprognosisimmunelandscapeanddrugcandidatesinbladdercancer
AT linyuda identificationofadysregulatedcircrnaassociatedgenesignatureforpredictingprognosisimmunelandscapeanddrugcandidatesinbladdercancer
AT huangshiwang identificationofadysregulatedcircrnaassociatedgenesignatureforpredictingprognosisimmunelandscapeanddrugcandidatesinbladdercancer
AT zhoumingli identificationofadysregulatedcircrnaassociatedgenesignatureforpredictingprognosisimmunelandscapeanddrugcandidatesinbladdercancer
AT huhailong identificationofadysregulatedcircrnaassociatedgenesignatureforpredictingprognosisimmunelandscapeanddrugcandidatesinbladdercancer